Investors

Top

Investor relations

We use innovative science to pursue novel treatments that address important medical challenges in neurological, autoimmune and rare diseases. Our therapies for multiple sclerosis and hemophilia are just the beginning.

Building the next Biogen


As we embark on building the Biogen of the future, we will focus on areas with the potential to have the most impact, developing life-changing treatments for people suffering from devastating conditions.

Review our 2015 performance

Stock information

Find Biogen’s current and historical stock information. 

NASDAQ: BIIB (Common Stock)

  • Volume
  • Today's Open $
  • Previous Close $
  • 52 Week High $
  • 52 Week Low $